These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25124245)

  • 1. [Evidence-based public health decision-making tools which can also be used for prioritising disease].
    Cediel-Becerra NM; Krause G
    Rev Salud Publica (Bogota); 2013; 15(5):694-706. PubMed ID: 25124245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resisting resistance: practical decision tools for choosing antimicrobials safely.
    Hannigan NS; Tolman DR; Larson EL
    J Am Acad Nurse Pract; 2012 May; 24(5):324-30. PubMed ID: 22551337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiently finding and using evidence to guide clinical practice and improve care.
    Akbashev MY; Pittman JR; Dressler DD
    JAAPA; 2017 Nov; 30(11):31-38. PubMed ID: 29064936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knowledge Management Implementation and the Tools Utilized in Healthcare for Evidence-Based Decision Making: A Systematic Review.
    Shahmoradi L; Safadari R; Jimma W
    Ethiop J Health Sci; 2017 Sep; 27(5):541-558. PubMed ID: 29217960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of research-based evidence in health system policy decision-making].
    Patiño D; Lavis JN; Moat K
    Rev Salud Publica (Bogota); 2013; 15(5):684-93. PubMed ID: 25124244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease control priorities for neglected tropical diseases: lessons from priority ranking based on the quality of evidence, cost effectiveness, severity of disease, catastrophic health expenditures, and loss of productivity.
    Strømme EM; Baerøe K; Norheim OF
    Dev World Bioeth; 2014 Dec; 14(3):132-41. PubMed ID: 23724925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond evidence--to ethics: a decision-making framework for health promotion, public health and health improvement.
    Tannahill A
    Health Promot Int; 2008 Dec; 23(4):380-90. PubMed ID: 18971394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Navigating the road ahead: public health challenges and the interactive systems framework for dissemination and implementation.
    Noonan RK; Wilson KM; Mercer SL
    Am J Community Psychol; 2012 Dec; 50(3-4):572-80. PubMed ID: 22806091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based decision-making (part 1): Origins and evolution in the health sciences.
    Bradt DA
    Prehosp Disaster Med; 2009; 24(4):298-305. PubMed ID: 19806553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCAMPs: A new tool for an old problem.
    Rathod RH
    J Hosp Med; 2015 Sep; 10(9):633-6. PubMed ID: 26126954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based medicine: can it be applied to stimulation of erythropoiesis for patients with malignancy?
    Rizzo JD
    Best Pract Res Clin Haematol; 2005; 18(3):439-48. PubMed ID: 15792918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Guyatt G; Akl EA; Oxman A; Wilson K; Puhan MA; Wilt T; Gutterman D; Woodhead M; Antman EM; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):256-61. PubMed ID: 23256168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achievements and Limitations of Evidence-Based Medicine.
    Sheridan DJ; Julian DG
    J Am Coll Cardiol; 2016 Jul; 68(2):204-13. PubMed ID: 27386775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do health-care decision makers find economic evaluations useful? The findings of focus group research in UK health authorities.
    Hoffmann C; Stoykova BA; Nixon J; Glanville JM; Misso K; Drummond MF
    Value Health; 2002; 5(2):71-8. PubMed ID: 11918822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using Electronic Medical Record Data to Improve HIV Patient Monitoring, Clinical Decision-Making, and Quality Improvement: Lessons from Rwanda.
    Karema N; Manzi A; Gaju E; Kayiganwa M; Remera E; Nshimyiryo A; Niyibizi G; Dukuze A; Gupta N; Amoroso C
    Stud Health Technol Inform; 2015; 216():880. PubMed ID: 26262182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based public health, community medicine, preventive care.
    Jenicek M; Stachenko S
    Med Sci Monit; 2003 Feb; 9(2):SR1-7. PubMed ID: 12601308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What counts as evidence in an evidence-based world?
    Mercuri M; Baigrie BS
    J Eval Clin Pract; 2019 Aug; 25(4):533-535. PubMed ID: 31270912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.